Trial · NCT04417699
Adverse events62
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 62
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Cramping | Gastrointestinal disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Abdominal Pain/Discomfort | Gastrointestinal disorders | TAS102 Plus Oxaliplatin | 4 | 13 | 4 |
| other | Anosmia | Nervous system disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Alanine aminotransferase increase | Investigations | TAS102 Plus Oxaliplatin | 2 | 13 | 4 |
| other | Aspartate aminotransferase increase | Investigations | TAS102 Plus Oxaliplatin | 2 | 13 | 3 |
| other | Blurred vision | Eye disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Cold sensitivity | General disorders | TAS102 Plus Oxaliplatin | 6 | 13 | 7 |
| other | Constipation | Gastrointestinal disorders | TAS102 Plus Oxaliplatin | 6 | 13 | 8 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Deep vein thrombosis | Vascular disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Dehydration | Metabolism and nutrition disorders | TAS102 Plus Oxaliplatin | 2 | 13 | 2 |
| other | Diarrhea | Gastrointestinal disorders | TAS102 Plus Oxaliplatin | 9 | 13 | 12 |
| other | Dizziness | Nervous system disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Dry skin | Skin and subcutaneous tissue disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Elevated liver fuction tests | Investigations | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Fatigue | General disorders | TAS102 Plus Oxaliplatin | 6 | 13 | 7 |
| other | Fecal urgency | Gastrointestinal disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Hypertenson | Vascular disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 2 |
| other | Hypomagnesemia | Metabolism and nutrition disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
| other | Hyponatremia | Metabolism and nutrition disorders | TAS102 Plus Oxaliplatin | 1 | 13 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04417699/events